{
    "2021-01-18": [
        [
            {
                "time": "",
                "original_text": "医药生物：中国创新药是否到了国际化的拐点？",
                "features": {
                    "keywords": [
                        "中国创新药",
                        "国际化",
                        "拐点"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药商业上市企业2020市值前十榜，2家位于“500亿俱乐部”",
                "features": {
                    "keywords": [
                        "医药商业",
                        "市值",
                        "500亿俱乐部"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药商业"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：珍惜短期“抱团股”调整 持续推荐“创新+自主消费”",
                "features": {
                    "keywords": [
                        "医药行业",
                        "抱团股",
                        "调整",
                        "创新",
                        "自主消费"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物：CXO景气度持续高涨 重点推荐药明康德、凯莱英等",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO",
                        "景气度",
                        "药明康德",
                        "凯莱英"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}